Management of muscular dystrophy. Pharmacological and physical aspects.
D000293:Adolescent; D002370:Casts, Surgical; D002986:Clinical Trials as Topic; D003286:Contracture / Q000517:prevention & control; D003401:Creatine / Q000652:urine; D003402:Creatine Kinase / Q000097:blood; D005260:Female; D006801:Humans; D008124:Locomotion; D008297:Male; D009136:Muscular Dystrophies / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*; D005082:Physical Exertion; D011187:Posture; D012600:Scoliosis / Q000517:prevention & control
D003402:Creatine Kinase; D003401:Creatine